Annual Accounts Receivable
N/A
December 31, 2023
Summary
- AVTX annual accounts receivable is not available.
Performance
AVTX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 30, 2024
Summary
- AVTX quarterly accounts receivable is not available.
Performance
AVTX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AVTX Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
AVTX Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Avalo Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $38.00 K(>+9900.0%) |
| Sep 2022 | - | $0.00(-100.0%) |
| Jun 2022 | - | $544.00 K(-42.0%) |
| Mar 2022 | - | $938.00 K(-11.5%) |
| Dec 2021 | $1.06 M(-51.3%) | $1.06 M(-26.1%) |
| Sep 2021 | - | $1.44 M(-65.2%) |
| Jun 2021 | - | $4.12 M(+31.6%) |
| Mar 2021 | - | $3.13 M(+43.8%) |
| Dec 2020 | $2.18 M | $2.18 M(+30.3%) |
| Sep 2020 | - | $1.67 M(-17.7%) |
| Jun 2020 | - | $2.03 M(-7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $2.19 M(+119.1%) |
| Dec 2019 | $1.00 M(+21.8%) | $1.00 M(-79.8%) |
| Sep 2019 | - | $4.96 M(+73.3%) |
| Jun 2019 | - | $2.86 M(+5.2%) |
| Mar 2019 | - | $2.72 M(+230.6%) |
| Dec 2018 | $822.30 K(-72.0%) | $822.30 K(-72.7%) |
| Sep 2018 | - | $3.01 M(-9.1%) |
| Jun 2018 | - | $3.31 M(+16.9%) |
| Mar 2018 | - | $2.83 M(-3.6%) |
| Dec 2017 | $2.94 M(+2115.1%) | $2.94 M(+2115.1%) |
| Dec 2016 | $132.50 K | $132.50 K |
FAQ
- What is the all time high annual accounts receivable for Avalo Therapeutics?
- What is the all time high quarterly accounts receivable for Avalo Therapeutics?
What is the all time high annual accounts receivable for Avalo Therapeutics?
Avalo Therapeutics all-time high annual accounts receivable is $2.94 M
What is the all time high quarterly accounts receivable for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly accounts receivable is $4.96 M